Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Aug 18;15(1):30232.
doi: 10.1038/s41598-025-15481-z.

Non-invasive evaluation of advanced glycation end products in hair as early markers of diabetes and aging

Affiliations

Non-invasive evaluation of advanced glycation end products in hair as early markers of diabetes and aging

Sayuri Kato et al. Sci Rep. .

Abstract

Continuous metabolic monitoring is essential for assessing lifestyle-related disease risks. Hair, an easily accessible tissue, allows for long-term metabolic evaluation, with glycated proteins linked to diabetic complications found in hair. We established a mass spectrometry system to detect advanced glycation end products (AGEs) in hair samples from humans and rats, assessing their variations with aging and disease. Hair samples were hydrolyzed and processed using a cation-exchange column for mass spectrometric analysis. Regardless of temperature variations, the levels of AGEs [Nε-(carboxymethyl)lysine (CML), and methylglyoxal-derived hydroimidazolone-1 (MG-H1)] in human hair remained stable for one week. Age and CML levels, or AGEs z-scores combined with CML and CEL levels in human hair samples, were positively correlated. In streptozotocin-induced insulin-deficient diabetic model (DM) rats, hair CEL and MG-H1 levels were higher than in non-diabetic rats. Receiver operating characteristic curve analysis showed an area under the curve of 1 for hair CEL and MG-H1 levels. Serum and hair CML levels were positively correlated. Hair AGE levels vary more between DM and non-DM rats than serum AGE levels. They remain stable under heat treatment and correlate with age, indicating that hair analysis is an effective non-invasive method for assessing metabolic fluctuations.

Keywords: Advanced glycation end products; Diabetes; Hair; Mass spectrometry; Non-invasive method.

PubMed Disclaimer

Conflict of interest statement

Declarations. Competing interests: The authors declare no competing interests. Ethical standards: This study adhered to the Declaration of Helsinki (amended at the 2013 WMA Fortaleza Meeting) and followed the Ethical Guidelines for Medical Research Involving Human Subjects (notified by the Ministry of Education, Culture, Sports, Science, and Technology and the Ministry of Health, Labor, and Welfare). This study was conducted with the deliberation and approval of the Ethics Review Committee of Living Appliances and Solutions Company, Panasonic Corporation (Approval No.: 20220617-A01) for the project titled “AGEs research for the development of a new value-adding facial device.”

Figures

Fig. 1
Fig. 1
Structures of AGEs and the position of the deuterium atom. The asterisk (*) indicates the position of the deuterium atom. (a) Nε-(carboxymethyllysine) (CML), (b) Nε-(carboxyethyllysine (CEL), (c) methylglyoxal-derived hydroimidazolone-1 (MG-H1).
Fig. 2
Fig. 2
Advanced glycation end products (AGEs) in human hair stored at various temperatures. (a) Levels of Nε-(carboxymethyl)lysine (CML), (b) levels of Nε-(carboxyethyl)lysine (CEL), (c) levels of methylglyoxal-derived hydroimidazolone-1 (MG-H1), (d) lysine (Lys) levels, (e) arginine (Arg) levels. Pink: 40 °C, green: 4 °C, blue: −80 °C. n = 3. Statistical analysis: Wilcoxon rank-sum test; * P < 0.05.
Fig. 3
Fig. 3
Correlation between AGEs levels in hair and age in healthy participants. Hair AGEs levels of 30 healthy females and their ages. (a) Hair Nε-(carboxymethyl)lysine (CML), (b) Hair Nε-(carboxyethyl)lysine (CEL), (c) Hair methylglyoxal-derived hydroimidazolone-1 (MG-H1), (d) Z-score with Hair CML + CEL levels and ages. Statistical analysis: Spearman’s analysis was performed with a significance level set at P < 0.05. Crosses inside the circles indicate non-significant correlations.Green and pink text indicate positive and negative correlations, respectively.
Fig. 4
Fig. 4
Comparison of AGEs levels in serum and hair in diabetes (DM)-induced and non-diabetic (control) rats at 12 weeks. (a) Serum Nε-(carboxymethyl)lysine (CML), (b) Hair CML, (c) Serum Nε-(carboxyethyl)lysine (CEL), (d) Hair CEL, (e) Serum methylglyoxal-derived hydroimidazolone-1 (MG-H1), (f) Hair MG-H1 levels. Control (n = 7) and DM (n = 6). Data are shown as box plots, with bold horizontal bars indicating median values. Statistical analysis: Wilcoxon rank-sum test; * P < 0.05; ** P < 0.01; *** P < 0.001.
Fig. 5
Fig. 5
Receiver operating characteristic (ROC) analysis of hair AGE levels in rats. ROC analysis was performed to assess the discriminatory ability of hair AGE levels and to determine the optimum cutoff point. The box plot shows individual sample values from the control (green, non-DM) and diabetes-induced (red, DM) rat groups. (a) Hair Nε-(carboxyethyl)lysine (CEL) and (b) Hair methylglyoxal-derived hydroimidazolone-1 (MG-H1) levels.
Fig. 6
Fig. 6
Correlation between hair and serum AGE levels in rats. Statistical analysis: Spearman’s analysis; significance level was set at P < 0.05. Green and pink text indicate positive and negative correlations, respectively.

References

    1. The international diabetes federation (IDF). IDF diabetes atlas 2021, (2021). Available from: https://diabetesatlas.org/atlas/tenth-edition/.
    1. Rigon, F. A. et al. Flash glucose monitoring system in special situations. Arch. Endocrinol. Metab.66, 883–894 (2022). (DOI 10.20945/2359-3997000000479) (PubMed: 35657123). - PMC - PubMed
    1. Kato, S., Matsumura, T., Sugawa, H. & Nagai, R. Correlation between serum advanced glycation end-products and vascular complications in patient with type 2 diabetes. Sci. Rep.14, 18722. 10.1038/s41598-024-69822-5) (2024). (PubMed: 39134632). - PMC - PubMed
    1. Lee, J., Yun, J. S. & Ko, S. H. Advanced glycation end products and their effect on vascular complications in type 2 diabetes mellitus. Nutrients14, 3086. 10.3390/nu14153086) (2022). (PubMed: 35956261). - PMC - PubMed
    1. Beisswenger, P. J. et al. Early progression of diabetic nephropathy correlates with methylglyoxal-derived advanced glycation end products. Diabetes Care. 36, 3234–3239. 10.2337/dc12-2689) (2013). (PubMed: 23780945). - PMC - PubMed

MeSH terms

LinkOut - more resources